Heart Valves, Transplants and Evaluating Treatments

Faulty Heart Valves

• You can think of heart valves as one-way doors that stop blood from flowing backwards.
• Valves can become faulty in two ways: stenosis (stiffening so they do not open fully) or insufficiency (leaking so they do not close properly, causing backflow).
• Both faults result in less efficient blood circulation. Sometimes this causes an abnormal sound called a heart murmur.

The Consequences of Faulty Valves

• When a valve leaks or stiffens, a specific chain of events occurs:
  1. Backflow or restricted flow means less oxygenated blood is pumped to the body.
  2. Less oxygen and glucose are delivered to cells.
  3. This results in less aerobic respiration.
  4. Less energy is released, leading to severe fatigue and breathlessness during exercise.

Valve Replacements

• Replacing a faulty valve with an artificial alternative restores the heart's function by acting as a new one-way door. This prevents backflow and restores circulatory efficiency, ensuring enough oxygen reaches cells for aerobic respiration.
• Mechanical Valves: Made from synthetic materials like titanium and plastics. They are highly durable and last a lifetime (20–30+ years). However, the turbulent blood flow over synthetic surfaces creates a high risk of thrombosis, requiring the patient to take lifelong anticoagulants.
• Biological Valves: Sourced from animal tissue (pigs/cows) or human donors. They do NOT require lifelong blood thinners. However, they are less durable, wearing out over 10–15 years, and carry a small risk of immune rejection.
• For younger patients, mechanical valves are often better to avoid repeat surgeries. Biological valves suit those who cannot take blood thinners, such as pregnant women.

Heart Failure: Transplants and Artificial Hearts

• What happens when the heart muscle itself fails completely? A biological transplant is often the only permanent solution, but finding a donor is difficult.

Biological Heart Transplants

• Sourced from human donors, biological transplants provide a permanent solution that can last decades.
• Disadvantages: There is a very low availability of donor hearts, leading to long waiting lists. There is also a high risk of rejection, as the patient's immune system identifies the donor's antigens as foreign.
• They are the most expensive cardiovascular treatment due to the major surgery, intensive care, and the ongoing cost of lifelong immunosuppressants to prevent rejection, which also makes patients vulnerable to other infections. Recovery is very long, taking 3–6 months.

Artificial Hearts

• An artificial heart or Ventricular Assist Device (VAD) is a mechanical pump made of synthetic materials. A VAD helps the existing heart pump blood, rather than replacing it entirely.
• Advantages: They have high availability and do NOT cause immune rejection because synthetic materials lack antigens. They are used as a bridge to transplant to keep a patient alive while waiting for a donor.
• Disadvantages: They are generally temporary fixes as mechanical parts can wear out and motors can fail. Patients must carry an external power source.
• There is a high risk of blood clots due to turbulent flow, meaning patients need lifelong blood-thinners, increasing the risk of excessive bleeding if injured.

Comparing Transplants and Artificial Hearts

Evaluating Cardiovascular Treatments

• In a 6-mark evaluation, examiners expect you to weigh treatments (drugs, mechanical devices, and transplants) based on cost, risk, and longevity to form a balanced concluding judgement.
• Statins (Drugs): The cheapest option for the NHS and carry no surgical risk, making them excellent for long-term preventative management, but they require daily compliance.
• Stents (Mechanical): More expensive than statins but provide immediate, life-saving intervention with long-lasting effects and short recovery times, though they carry surgical risks.
• Transplants (Biological): The most expensive treatment due to intensive care and lifelong immunosuppressants. However, they provide the best longevity (lasting decades) for complete heart failure.
• Concluding Judgement: Statins are best for low-cost, low-risk prevention. Stents are superior for immediate, localised blockages. Transplants are the ultimate, permanent solution for complete heart failure, but their extreme cost, lack of donors, and high surgical and rejection risks mean they must be reserved as an absolute last resort.